78
Participants
Start Date
April 28, 2025
Primary Completion Date
October 31, 2029
Study Completion Date
October 31, 2029
SX-682
SX-682 is supplied as 100mg film coated tablets.
Apalutamide
Apalutamide is supplied as 60mg film coated tablets.
NOT_YET_RECRUITING
Oncology Institute of Southern Switzerland, Bellinzona
NOT_YET_RECRUITING
Belfast Health and Social Care Trust, Belfast
NOT_YET_RECRUITING
Cambridge University Hospitals NHS Foundation Trust, Cambridge
RECRUITING
The Royal Marsden NHS Foundation Trust - Drug Development Unit, Sutton
Prostate Cancer UK
OTHER
Janssen Pharmaceutica N.V., Belgium
INDUSTRY
Oncology Institute of Southern Switzerland
OTHER
Syntrix Biosystems, Inc.
INDUSTRY
Royal Marsden NHS Foundation Trust
OTHER
Cambridge University Hospitals NHS Foundation Trust
OTHER
Belfast Health and Social Care Trust
OTHER
Institute of Oncology Research (IOR)
UNKNOWN
Institute of Cancer Research, United Kingdom
OTHER